Genelux Share Price

Genelux Share Price

NASDAQ: GNLX | Micro Cap | Healthcare
$2.17
-$0.14 (-6.06%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Genelux Stock Performance

Open
$2.33
Prev. Close
$2.31
Circuit Range
N/A
Day Range
$2.13 - $2.33
Year Range
$1.77 - $5.68
Volume
5,523
Average Traded
$2.17

Genelux Share Price Today

As of 22 November 2026, Genelux Corporation's share price is $2.17. The stock opened at $2.33, compared to its previous close of $2.31. During today's trading session, Genelux Corporation's share price traded between $2.13 and $2.33, with an average price of $2.23. Over the past 52 weeks, the stock has recorded a high of $5.68 and a low of $1.77. In terms of performance, Genelux Corporation's share price has declined by 29.08% over the last six months and is down 61.28% on a year-on-year basis.

Genelux Share Price Chart

Line chart of the Genelux price trend over the selected period. The price fell overall, ranging from 2.13 to 2.33, ending at 2.17.
$2.13$2.33
L
Show Current Price
H

Genelux Stock Fundamentals & Key Indicators

Market Cap
$80.67M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.80
Revenue (TTM)
$10.00M
Return On Equity (TTM)
-413.28%
Profit Margin
-321500.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-11.24%

Genelux Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.01$0.00$0.00$0.00
Net Profit-$9.25-$8.93-$9.47-$10.29
Net Profit Margin-92500.00%N/AN/AN/A
Income ChangeN/A3.46%-6.05%-8.66%

Genelux Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.17$0.01$0.01
Net Profit-$28.30-$29.87-$32.15
Net Profit Margin-16647.06%-298700.00%-321500.00%
Income ChangeN/A-5.55%-7.63%

Genelux Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets3.93.173.69
Current Assets15.1331.5524.2
Total Assets19.0334.7227.89
Non Current Liabilities1.261.541.87
Current Liabilities6.236.96.55
Total Liabilities7.488.448.42
Shareholders' Equity11.5426.2719.47

Genelux Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-25.27-21.23-20.28
Investing12.14-8.13-14.72
Financing9.928.5144.02

About Genelux

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Genelux Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.10
$2.17
+2.84%
Oct 2026
$2.48
$2.11
-16.60%
Sep 2026
$2.58
$2.53
-12.15%
Aug 2026
$2.96
$2.88
-1.87%
Jul 2026
$3.01
$2.94
-2.81%
Jun 2026
$3.00
$3.02
-1.31%
May 2026
$2.67
$3.06
+14.82%
Apr 2026
$2.48
$2.67
+10.58%
Mar 2026
$2.84
$2.41
-19.13%
Feb 2026
$2.73
$2.98
+11.61%
Jan 2026
$4.54
$2.67
-38.69%
Dec 2025
$5.25
$4.36
-22.30%

Genelux Share Price FAQs